AEHR TEST SYSTEMS — Director's Dealing 2020

Feb 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2020-02-12

Reporting Person: POSEDEL RHEA J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	M	30000	$1.28000	Acquired	78794	Direct
2020-02-12	Common Stock	S	30000	$2.2700	Disposed	48794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Incentive Stock Option (right to buy)	$1.2800	M	30000	Disposed	2020-06-25	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	902422	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.40, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for CY2019 of 1,960 shares on 11/22/2019. The closing price was $2.02 per share.

F3: Mr. Rhea Posedel received a required minimum distribution from ESOP plan for the following: CY2017 of 328 shares on 11/17/2017 when the closing price was $3.19 per share; CY2018 of 2,880 shares on 11/29/2018 when the closing price was $1.93 per share.

F4: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.